Prognostic effect of human leukocyte antigen class I and II alleles on chronic hepatitis C patients treated by pegylated interferon-alfa plus ribavirin in Taiwan.

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Prognostic effect of human leukocyte antigen class I and II alleles on chronic hepatitis C patients treated by pegylated interferon-alfa plus ribavirin in Taiwan.

Hepato-gastroenterology - 1 Jan 2000

Tseng Kuo-Chih, Chang Chin-Kuo, Chou An-Liang, Hsieh Yu-Hsi, Tseng Chang-An, Lai Ning-Sheng

Abstract excerpt

BACKGROUND/AIMS: To investigate the influence of human leukocyte antigen (HLA) class I and II alleles on the response in chronic hepatitis C (CHC) patients receiving combination therapy with pegylated interferon-alfa and ribavirin. METHODOLOGY: One hundred and six CHC patients who accomplished combination treatment were enrolled. Sixty-seven patients achieved sustained virologic response (SVR). HLA-A, -B, -C,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Drug Therapy, Combination
Share to Genes, MHC Class I
Share to Genes, MHC Class II

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to HLA-DR Antigens

Share to Interferon-alpha

Share to Interferon alpha-2

Share to Polyethylene Glycols

Share to Ribavirin

Source

Open in PubMed

Identifiers

PMID: 20698208

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.